Charles Schwab’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.37B | Sell |
13,259,314
-415,611
| -3% | -$37.1M | 0.18% | 91 |
|
|
2026
Q1 | $983M | Sell |
13,674,925
-182,421
| -1% | -$14.1M | 0.15% | 104 |
|
|
2025
Q4 | $1.1B | Sell |
13,857,346
-83,285
| -0.6% | -$6.57M | 0.17% | 100 |
|
|
2025
Q3 | $1.05B | Buy |
13,940,631
+157,157
| +1% | +$10.8M | 0.17% | 101 |
|
|
2025
Q2 | $951M | Buy |
13,783,474
+135,601
| +1% | +$8.89M | 0.16% | 104 |
|
|
2025
Q1 | $925M | Buy |
13,647,873
+728,924
| +6% | +$43.6M | 0.17% | 102 |
|
|
2024
Q4 | $580M | Buy |
12,918,949
+710,281
| +6% | +$39.8M | 0.11% | 158 |
|
|
2024
Q3 | $768M | Buy |
12,208,668
+304,386
| +3% | +$17.8M | 0.15% | 118 |
|
|
2024
Q2 | $703M | Buy |
11,904,282
+366,909
| +3% | +$23M | 0.13% | 134 |
|
|
2024
Q1 | $904M | Sell |
11,537,373
-1,412,916
| -11% | -$108M | 0.21% | 83 |
|
|
2023
Q4 | $993M | Buy |
12,950,289
+232,464
| +2% | +$16.5M | 0.25% | 70 |
|
|
2023
Q3 | $865M | Buy |
12,717,825
+324,391
| +3% | +$23M | 0.25% | 71 |
|
|
2023
Q2 | $836M | Buy |
12,393,434
+397,285
| +3% | +$28.3M | 0.24% | 75 |
|
|
2023
Q1 | $873M | Sell |
11,996,149
-58,860
| -0.5% | -$4.94M | 0.27% | 71 |
|
|
2022
Q4 | $1.1B | Buy |
12,055,009
+155,280
| +1% | +$15M | 0.36% | 50 |
|
|
2022
Q3 | $1.13B | Buy |
11,899,729
+224,538
| +2% | +$22.2M | 0.41% | 44 |
|
|
2022
Q2 | $1.08B | Sell |
11,675,191
-24,093
| -0.2% | -$2.35M | 0.38% | 51 |
|
|
2022
Q1 | $1.18B | Buy |
11,699,284
+134,457
| +1% | +$14.1M | 0.36% | 49 |
|
|
2021
Q4 | $1.19B | Buy |
11,564,827
+559,559
| +5% | +$51.7M | 0.35% | 53 |
|
|
2021
Q3 | $934M | Buy |
11,005,268
+84,565
| +0.8% | +$7.08M | 0.31% | 64 |
|
|
2021
Q2 | $911M | Buy |
10,920,703
+187,276
| +2% | +$15.3M | 0.3% | 63 |
|
|
2021
Q1 | $807M | Sell |
10,733,427
-102,220
| -0.9% | -$7.45M | 0.3% | 65 |
|
|
2020
Q4 | $740M | Sell |
10,835,647
-18,526
| -0.2% | -$1.2M | 0.29% | 64 |
|
|
2020
Q3 | $634M | Sell |
10,854,173
-506,535
| -4% | -$31.5M | 0.29% | 68 |
|
|
2020
Q2 | $738M | Sell |
11,360,708
-5,615,306
| -33% | -$354M | 0.36% | 53 |
|
|
2020
Q1 | $1.01B | Buy |
16,976,014
+5,078,541
| +43% | +$339M | 0.59% | 29 |
|
|
2019
Q4 | $884M | Buy |
11,897,473
+220,868
| +2% | +$15.5M | 0.48% | 33 |
|
|
2019
Q3 | $736M | Buy |
11,676,605
+360,308
| +3% | +$21.4M | 0.43% | 37 |
|
|
2019
Q2 | $617M | Buy |
11,316,297
+491,729
| +5% | +$26.5M | 0.38% | 46 |
|
|
2019
Q1 | $584M | Buy |
10,824,568
+619,236
| +6% | +$38.2M | 0.37% | 43 |
|
|
2018
Q4 | $669M | Buy |
10,205,332
+2,414,491
| +31% | +$180M | 0.51% | 34 |
|
|
2018
Q3 | $613M | Buy |
7,790,841
+458,176
| +6% | +$32.8M | 0.41% | 41 |
|
|
2018
Q2 | $472M | Buy |
7,332,665
+300,887
| +4% | +$19.8M | 0.34% | 48 |
|
|
2018
Q1 | $437M | Buy |
7,031,778
+2,720,334
| +63% | +$195M | 0.34% | 51 |
|
|
2017
Q4 | $313M | Buy |
4,311,444
+71,916
| +2% | +$5.23M | 0.25% | 66 |
|
|
2017
Q3 | $345M | Buy |
4,239,528
+219,536
| +5% | +$17.4M | 0.3% | 55 |
|
|
2017
Q2 | $323M | Buy |
4,019,992
+273,574
| +7% | +$21.6M | 0.3% | 51 |
|
|
2017
Q1 | $294M | Buy |
3,746,418
+40,014
| +1% | +$3.19M | 0.29% | 53 |
|
|
2016
Q4 | $292M | Buy |
3,706,404
+258,981
| +8% | +$21M | 0.32% | 51 |
|
|
2016
Q3 | $307M | Buy |
3,447,423
+32,623
| +1% | +$3.08M | 0.36% | 46 |
|
|
2016
Q2 | $327M | Buy |
3,414,800
+44,554
| +1% | +$4.44M | 0.41% | 44 |
|
|
2016
Q1 | $350M | Buy |
3,370,246
+64,666
| +2% | +$6.29M | 0.46% | 40 |
|
|
2015
Q4 | $323M | Buy |
3,305,580
+88,738
| +3% | +$8.69M | 0.44% | 41 |
|
|
2015
Q3 | $310M | Sell |
3,216,842
-14,331
| -0.4% | -$1.51M | 0.46% | 38 |
|
|
2015
Q2 | $339M | Buy |
3,231,173
+57,547
| +2% | +$5.88M | 0.47% | 34 |
|
|
2015
Q1 | $328M | Buy |
3,173,626
+115,841
| +4% | +$11.7M | 0.46% | 36 |
|
|
2014
Q4 | $294M | Buy |
3,057,785
+105,035
| +4% | +$9.25M | 0.44% | 37 |
|
|
2014
Q3 | $235M | Buy |
2,952,750
+79,403
| +3% | +$6.26M | 0.39% | 45 |
|
|
2014
Q2 | $217M | Buy |
2,873,347
+34,417
| +1% | +$2.6M | 0.36% | 52 |
|
|
2014
Q1 | $213M | Buy |
2,838,930
+95,969
| +3% | +$6.78M | 0.38% | 46 |
|
|
2013
Q4 | $196M | Buy |
2,742,961
+6,861
| +0.3% | +$441K | 0.37% | 47 |
|
|
2013
Q3 | $157M | Buy |
2,736,100
+110,465
| +4% | +$6.58M | 0.32% | 60 |
|
|
2013
Q2 | $151M | Buy |
+2,625,635
| New | +$152M | 0.34% | 58 |
|
Other funds holding CVS
Charles Schwab's CVS Position: Q2 2026 in Review
Charles Schwab reduced its CVS Health (CVS) stake by 3% in Q2 2026, selling an estimated $37.1M and leaving 13,259,314 shares worth $1.37B. The position accounts for 0.18% of the portfolio, ranked #91.
Charles Schwab first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Charles Schwab held 13,259,314 shares of CVS Health worth $1.37B as of Q2 2026.
- Charles Schwab sold 415,611 CVS Health shares in Q2 2026, an estimated $37.1M.
- CVS Health made up 0.18% of Charles Schwab's portfolio in Q2 2026, its #91 holding.
- Charles Schwab first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.